SLXNWSilexion Therapeutics Corpvs its industry peers
A metric-by-metric comparison of Silexion Therapeutics Corp against Biological Products, (No Diagnostic Substances) — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLXNWEsta | $77844#11 | 0.0x#1 | 1.8x#3 | — | — | 27.9%#8 | — | -27072.7%#3 | — | — | -63.3%#5 | — |
| SLXN | $2M#5 | 0.0x#3 | 55.3x#4 | — | — | 27.9%#8 | — | -27072.7%#3 | — | — | -98.8%#10 | — |
| CRIS | $2M#6 | 0.1x#4 | 0.5x#2 | 0.2x#3 | -13.4%#7 | 82.5%#4 | -60.5%#4 | -161.5%#2 | -87.3%#1 | — | -97.1%#9 | — |
| SCLXW | $1M#7 | — | — | 0.0x#1 | -46.5%#8 | -413.8%#13 | -1143.7%#5 | — | — | 4#1 | 225.4%#1 | — |
| VIVS | $4M#4 | — | — | 27.3x#6 | -9.0%#6 | -456.4%#14 | -8768.7%#8 | — | — | — | -93.8%#8 | — |
| TVGNW | $312554#8 | — | — | — | — | -91.4%#12 | — | — | — | — | -7.7%#2 | — |
| JSPRW | $296144#9 | — | 0.2x#1 | — | — | 100.0%#3 | — | -0.0%#1 | — | — | -91.1%#7 | — |
| ABPWW | $116152#10 | 0.0x#2 | — | 0.6x#4 | 50.0%#2 | 60.0%#5 | -4618.6%#6 | — | — | — | -50.8%#4 | — |
| ABPO | — | — | — | — | 50.0%#2 | 60.0%#5 | -4618.6%#6 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#1 | 37.8%#7 | -38.6%#3 | — | — | — | — | — |
| AGMB | $415M#2 | — | — | — | — | — | — | — | — | — | — | — |
| AGTX | — | — | — | — | -100.0%#9 | 14.4%#10 | — | — | — | — | — | — |
| ALVO | $1.8B#1 | — | — | 3.1x#5 | 19.7%#4 | 112.0%#1 | 13.3%#1 | — | — | — | -24.8%#3 | — |
| ALVOW | $100M#3 | — | — | 0.2x#2 | 19.7%#4 | 112.0%#1 | 13.3%#1 | — | — | — | -70.9%#6 | — |
| APTN | — | — | — | — | — | -65.5%#11 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-20.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice